NATURE’S SUNSHINE PRODUCTS, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$1.20 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2019-03-08
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-12-31 was $3.33M, a 281.58% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-09-30 was $1.61M, a 68.47% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-06-30 was $2.40M, a 32.54% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-03-31 was $4.20M, a 58.94% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2018 was -$1.20M.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2017 was -$13.82M, a 2146.96% decline from fiscal 2016.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2016 was $675.00K, a 94.15% decline from fiscal 2015.
- NATURE’S SUNSHINE PRODUCTS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was $11.54M, a 41.59% decline from fiscal 2014.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$1.20M 10-K · filed 2019-03-08 | |||
| 2017-12-31 | -$13.82M 10-K · filed 2019-03-08 | |||
| 2016-12-31 | $675.00K 10-K · filed 2019-03-08 | |||
| 2015-12-31 | $3.33M 10-K · filed 2017-03-14 | $4.94M derived: sum of 2 quarters · filed 2017-03-14 | $7.34M derived: sum of 3 quarters · filed 2017-03-14 | $11.54M 10-K · filed 2018-03-16 |
| 2015-09-30 | $1.61M 10-K · filed 2017-03-14 | $4.00M derived: sum of 2 quarters · filed 2017-03-14 | $8.21M derived: sum of 3 quarters · filed 2017-03-14 | $9.08M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $2.40M 10-K · filed 2017-03-14 | $6.60M derived: sum of 2 quarters · filed 2017-03-14 | $7.47M derived: sum of 3 quarters · filed 2017-03-14 | $12.57M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $4.20M 10-K · filed 2017-03-14 | $5.08M derived: sum of 2 quarters · filed 2017-03-14 | $10.17M derived: sum of 3 quarters · filed 2017-03-14 | $13.72M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $874.00K 10-K · filed 2016-03-14 | $5.97M derived: sum of 2 quarters · filed 2016-03-14 | $9.52M derived: sum of 3 quarters · filed 2016-03-14 | $19.76M 10-K · filed 2017-03-14 |
| 2014-09-30 | $5.10M 10-K · filed 2016-03-14 | $8.65M derived: sum of 2 quarters · filed 2016-03-14 | $18.88M derived: sum of 3 quarters · filed 2016-03-14 | |
| 2014-06-30 | $3.55M 10-K · filed 2016-03-14 | $13.79M derived: sum of 2 quarters · filed 2016-03-14 | ||
| 2014-03-31 | $10.24M 10-K · filed 2016-03-14 | |||
| 2013-12-31 | $17.65M 10-K · filed 2016-03-14 | |||
| 2011-06-30 | $5.61M 10-Q · filed 2011-08-05 | $12.24M 10-Q · filed 2011-08-05 | ||
| 2010-06-30 | $1.41M 10-Q · filed 2011-08-05 | $6.18M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |